Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1998 Jul;228(1):112–122. doi: 10.1097/00000658-199807000-00017

Mechanisms of neutropenia involving myeloid maturation arrest in burn sepsis.

M Shoup 1, J M Weisenberger 1, J L Wang 1, J M Pyle 1, R L Gamelli 1, R Shankar 1
PMCID: PMC1191436  PMID: 9671075

Abstract

OBJECTIVE: To determine the mechanisms that lead to the decrease in bone marrow production of neutrophils during burn sepsis. SUMMARY BACKGROUND DATA: Impaired bone marrow granulopoiesis during burn sepsis often results in neutropenia despite elevated circulating levels of granulocyte colony-stimulating factor (G-CSF). To date, neither the specific stages of neutrophil maturation involved in the bone marrow suppression nor the mechanisms for the impairment have been determined. METHODS: Peripheral blood absolute neutrophil count and G-CSF levels were determined in mice 3 days after randomization to control, burn alone, or burn plus a topical inoculation of Pseudomonas aeruginosa (1000 colony-forming units). Bone marrow aspirates were analyzed for their neutrophil differentiation patterns by Gr-1 antigen expression and their G-CSF receptor status. Histologic analysis of liver, lung, spleen, and wound site was performed. RESULTS: In burn sepsis, absolute neutrophil count was reduced whereas plasma G-CSF levels were elevated, and myeloid differentiation was significantly shifted toward the immature mitotic myeloid cells. Bone marrow G-CSF receptor mRNA levels and G-CSF-stimulated proliferation were substantially decreased in burn sepsis. Histologic analysis revealed no significant neutrophil infiltration into the tissues. CONCLUSIONS: In thermal injury with superimposed sepsis, neutropenia and myeloid maturation arrest, despite the elevated levels of G-CSF, correlate with the reduction in bone marrow G-CSF receptor expression. These observations may provide a potential mechanism for neutropenia in sepsis.

Full text

PDF
112

Images in this article

117Figure 5.
on p.117
118Figure 6.
on p.118
119Figure 8.
on p.119
120Figure 9.
on p.120

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austin G. E., Chan W. C., Zhao W., Racine M. Myeloperoxidase gene expression in normal granulopoiesis and acute leukemias. Leuk Lymphoma. 1994 Oct;15(3-4):209–226. doi: 10.3109/10428199409049717. [DOI] [PubMed] [Google Scholar]
  2. Bolin R. W., Robinson W. A. Bacterial, serum and cellular modulation of granulopoietic activity. J Cell Physiol. 1977 Aug;92(2):145–153. doi: 10.1002/jcp.1040920202. [DOI] [PubMed] [Google Scholar]
  3. Borregaard N., Sehested M., Nielsen B. S., Sengeløv H., Kjeldsen L. Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood. 1995 Feb 1;85(3):812–817. [PubMed] [Google Scholar]
  4. Bradley T. R., Metcalf D. The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci. 1966 Jun;44(3):287–299. doi: 10.1038/icb.1966.28. [DOI] [PubMed] [Google Scholar]
  5. Cao L., Deng S., Chang L. [Changes in serum granulocyte colony-stimulating factor (G-CSF) in burned patients]. Zhonghua Wai Ke Za Zhi. 1995 Jul;33(7):403–405. [PubMed] [Google Scholar]
  6. Cheers C., Haigh A. M., Kelso A., Metcalf D., Stanley E. R., Young A. M. Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs. Infect Immun. 1988 Jan;56(1):247–251. doi: 10.1128/iai.56.1.247-251.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  8. Demling R. H. Burns. N Engl J Med. 1985 Nov 28;313(22):1389–1398. doi: 10.1056/NEJM198511283132205. [DOI] [PubMed] [Google Scholar]
  9. Duque R. E., Phan S. H., Hudson J. L., Till G. O., Ward P. A. Functional defects in phagocytic cells following thermal injury. Application of flow cytometric analysis. Am J Pathol. 1985 Jan;118(1):116–127. [PMC free article] [PubMed] [Google Scholar]
  10. Elbaz O., Budel L. M., Hoogerbrugge H., Touw I. P., Delwel R., Mahmoud L. A., Löwenberg B. Tumor necrosis factor downregulates granulocyte-colony-stimulating factor receptor expression on human acute myeloid leukemia cells and granulocytes. J Clin Invest. 1991 Mar;87(3):838–841. doi: 10.1172/JCI115087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Eurenius K., Brouse R. O. Granulocyte kinetics after thermal injury. Am J Clin Pathol. 1973 Sep;60(3):337–342. doi: 10.1093/ajcp/60.3.337. [DOI] [PubMed] [Google Scholar]
  12. Fleming T. J., Fleming M. L., Malek T. R. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol. 1993 Sep 1;151(5):2399–2408. [PubMed] [Google Scholar]
  13. Fukunaga R., Ishizaka-Ikeda E., Seto Y., Nagata S. Expression cloning of a receptor for murine granulocyte colony-stimulating factor. Cell. 1990 Apr 20;61(2):341–350. doi: 10.1016/0092-8674(90)90814-u. [DOI] [PubMed] [Google Scholar]
  14. Gamelli R. L., He L. K., Liu H. Marrow granulocyte-macrophage progenitor cell response to burn injury as modified by endotoxin and indomethacin. J Trauma. 1994 Sep;37(3):339–346. doi: 10.1097/00005373-199409000-00002. [DOI] [PubMed] [Google Scholar]
  15. Hansbrough J. F., Zapata-Sirvent R. L., Peterson V. M. Immunomodulation following burn injury. Surg Clin North Am. 1987 Feb;67(1):69–92. doi: 10.1016/s0039-6109(16)44134-4. [DOI] [PubMed] [Google Scholar]
  16. Hestdal K., Ruscetti F. W., Ihle J. N., Jacobsen S. E., Dubois C. M., Kopp W. C., Longo D. L., Keller J. R. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol. 1991 Jul 1;147(1):22–28. [PubMed] [Google Scholar]
  17. Kawakami M., Tsutsumi H., Kumakawa T., Abe H., Hirai M., Kurosawa S., Mori M., Fukushima M. Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood. 1990 Nov 15;76(10):1962–1964. [PubMed] [Google Scholar]
  18. Lieschke G. J., Grail D., Hodgson G., Metcalf D., Stanley E., Cheers C., Fowler K. J., Basu S., Zhan Y. F., Dunn A. R. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 1994 Sep 15;84(6):1737–1746. [PubMed] [Google Scholar]
  19. Lundblad R., Nesland J. M., Giercksky K. E. Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats. Crit Care Med. 1996 May;24(5):820–826. doi: 10.1097/00003246-199605000-00016. [DOI] [PubMed] [Google Scholar]
  20. Lundblad R., Wang M. Y., Kvalheim G., Lingaas E., Giercksky K. E. Granulocyte colony-stimulating factor improves myelopoiesis and host defense in fulminant intra-abdominal sepsis in rats. Shock. 1995 Jul;4(1):68–73. doi: 10.1097/00024382-199507000-00011. [DOI] [PubMed] [Google Scholar]
  21. Lübbert M., Herrmann F., Koeffler H. P. Expression and regulation of myeloid-specific genes in normal and leukemic myeloid cells. Blood. 1991 Mar 1;77(5):909–924. [PubMed] [Google Scholar]
  22. McKinstry W. J., Li C. L., Rasko J. E., Nicola N. A., Johnson G. R., Metcalf D. Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood. 1997 Jan 1;89(1):65–71. [PubMed] [Google Scholar]
  23. Metcalf D. Hematopoietic regulators: redundancy or subtlety? Blood. 1993 Dec 15;82(12):3515–3523. [PubMed] [Google Scholar]
  24. Metcalf D. The hemopoietic regulators--an embarrassment of riches. Bioessays. 1992 Dec;14(12):799–805. doi: 10.1002/bies.950141202. [DOI] [PubMed] [Google Scholar]
  25. Metcalf D., Willson T., Rossner M., Lock P. Receptor insertion into factor-dependent murine cell lines to develop specific bioassays for murine G-CSF and M-CSF and human GM-CSF. Growth Factors. 1994;11(2):145–152. doi: 10.3109/08977199409001056. [DOI] [PubMed] [Google Scholar]
  26. Miller C. L., Baker C. C. Changes in lymphocyte activity after thermal injury. The role of suppressor cells. J Clin Invest. 1979 Feb;63(2):202–210. doi: 10.1172/JCI109290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Moncrief J. A. Burns. N Engl J Med. 1973 Mar 1;288(9):444–454. doi: 10.1056/NEJM197303012880905. [DOI] [PubMed] [Google Scholar]
  28. Mooney D. P., Gamelli R. L., O'Reilly M., Hebert J. C. Recombinant human granulocyte colony-stimulating factor and Pseudomonas burn wound sepsis. Arch Surg. 1988 Nov;123(11):1353–1357. doi: 10.1001/archsurg.1988.01400350067010. [DOI] [PubMed] [Google Scholar]
  29. Newsome T. W., Eurenius K. Suppression of granulocyte and platelet production by pseudomonas burn wound infection. Surg Gynecol Obstet. 1973 Mar;136(3):375–379. [PubMed] [Google Scholar]
  30. Nicola N. A., Metcalf D. Binding of 125I-labeled granulocyte colony-stimulating factor to normal murine hemopoietic cells. J Cell Physiol. 1985 Aug;124(2):313–321. doi: 10.1002/jcp.1041240222. [DOI] [PubMed] [Google Scholar]
  31. Nicola N. A., Metcalf D. Binding of the differentiation-inducer, granulocyte-colony-stimulating factor, to responsive but not unresponsive leukemic cell lines. Proc Natl Acad Sci U S A. 1984 Jun;81(12):3765–3769. doi: 10.1073/pnas.81.12.3765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Nicola N. A., Metcalf D. Biochemical properties of differentiation factors for murine myelomonocytic leukemic cells in organ conditioned media--separation from colony-stimulating factors. J Cell Physiol. 1981 Nov;109(2):253–264. doi: 10.1002/jcp.1041090208. [DOI] [PubMed] [Google Scholar]
  33. Nicola N. A., Metcalf D., Matsumoto M., Johnson G. R. Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. J Biol Chem. 1983 Jul 25;258(14):9017–9023. [PubMed] [Google Scholar]
  34. Nicola N. A., Vadas M. A., Lopez A. F. Down-modulation of receptors for granulocyte colony-stimulating factor on human neutrophils by granulocyte-activating agents. J Cell Physiol. 1986 Sep;128(3):501–509. doi: 10.1002/jcp.1041280320. [DOI] [PubMed] [Google Scholar]
  35. Peterson V. M., Robinson W. A., Wallner S. F., Rundus C., Hansbrough J. F. Granulocyte stem cells are decreased in humans with fatal burns. J Trauma. 1985 May;25(5):413–418. doi: 10.1097/00005373-198505000-00007. [DOI] [PubMed] [Google Scholar]
  36. Peterson V. M., Rundus C. H., Reinoehl P. J., Schroeter S. R., McCall C. A., Bartle E. J. The myelopoietic effects of a Serratia marcescens-derived biologic response modifier in a mouse model of thermal injury. Surgery. 1992 Apr;111(4):447–454. [PubMed] [Google Scholar]
  37. Peterson V., Hansbrough J., Buerk C., Rundus C., Wallner S., Smith H., Robinson W. A. Regulation of granulopoiesis following severe thermal injury. J Trauma. 1983 Jan;23(1):19–24. doi: 10.1097/00005373-198301000-00004. [DOI] [PubMed] [Google Scholar]
  38. Rosenthal S. M. A procedure for measurement of wound healing, with special reference to burns. Proc Soc Exp Biol Med. 1966 Nov;123(2):347–349. doi: 10.3181/00379727-123-31484. [DOI] [PubMed] [Google Scholar]
  39. Silver G. M., Gamelli R. L., O'Reilly M. The beneficial effect of granulocyte colony-stimulating factor (G-CSF) in combination with gentamicin on survival after Pseudomonas burn wound infection. Surgery. 1989 Aug;106(2):452–456. [PubMed] [Google Scholar]
  40. Smith W. S., Sumnicht G. E., Sharpe R. W., Samuelson D., Millard F. E. Granulocyte colony-stimulating factor versus placebo in addition to penicillin G in a randomized blinded study of gram-negative pneumonia sepsis: analysis of survival and multisystem organ failure. Blood. 1995 Aug 15;86(4):1301–1309. [PubMed] [Google Scholar]
  41. Solomkin J. S., Nelson R. D., Chenoweth D. E., Solem L. D., Simmons R. L. Regulation of neutrophil migratory function in burn injury by complement activation products. Ann Surg. 1984 Dec;200(6):742–746. doi: 10.1097/00000658-198412000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Steinman R. A., Tweardy D. J. Granulocyte colony-stimulating factor receptor mRNA upregulation is an immediate early marker of myeloid differentiation and exhibits dysfunctional regulation in leukemic cells. Blood. 1994 Jan 1;83(1):119–127. [PubMed] [Google Scholar]
  43. Stratta R. J., Warden G. D., Ninnemann J. L., Saffle J. R. Immunologic parameters in burned patients: effect of therapeutic interventions. J Trauma. 1986 Jan;26(1):7–17. doi: 10.1097/00005373-198601000-00002. [DOI] [PubMed] [Google Scholar]
  44. Struzyna J., Pojda Z., Braun B., Chomicka M., Sobiczewska E., Wrembel J. Serum cytokine levels (IL-4, IL-6, IL-8, G-CSF, GM-CSF) in burned patients. Burns. 1995 Sep;21(6):437–440. doi: 10.1016/0305-4179(95)00018-7. [DOI] [PubMed] [Google Scholar]
  45. Toda H., Murata A., Matsuura N., Uda K., Oka Y., Tanaka N., Mori T. Therapeutic efficacy of granulocyte colony stimulating factor against rat cecal ligation and puncture model. Stem Cells. 1993 May;11(3):228–234. doi: 10.1002/stem.5530110310. [DOI] [PubMed] [Google Scholar]
  46. Venturelli D., Shirsat N., Gemperlein I., Bittenbender S., Hudson S., Rovera G. Nucleotide sequence of cDNA for murine myeloperoxidase. Nucleic Acids Res. 1989 Jul 25;17(14):5852–5852. doi: 10.1093/nar/17.14.5852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Walker H. L., Mason A. D., Jr A standard animal burn. J Trauma. 1968 Nov;8(6):1049–1051. doi: 10.1097/00005373-196811000-00006. [DOI] [PubMed] [Google Scholar]
  48. Warden G. D., Mason A. D., Jr, Pruitt B. A., Jr Evaluation of leukocyte chemotaxis in vitro in thermally injured patients. J Clin Invest. 1974 Oct;54(4):1001–1004. doi: 10.1172/JCI107815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Watari K., Asano S., Shirafuji N., Kodo H., Ozawa K., Takaku F., Kamachi S. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood. 1989 Jan;73(1):117–122. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES